17 results
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
#pharmacology #table ... comparison #drugs #treatment ... #pharmacotherapy ... #dermatology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#pharmacology #treatment ... #medications #table ... #pharmacotherapy ... #hematology #warfarin ... #dosing
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
including tips for using ... #medications #table ... #treatment #drugs ... #pharmacotherapy
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
with caution - e.g ... pharmacology #comparison #treatment ... #medications #dosing ... #drugs #table # ... pharmacotherapy
Acute Coronary Syndrome (ACS) Definitions - Stable Angina, Unstable Angina, NSTEMI, STEMI
1 STABLE ANGINA - Angina
Definitions - Stable ... NSTEMI, STEMI 1 STABLE ... the setting of a stable ... 3 NSTEMI - During ... #Diagnosis #Cardiology
Junctional Rhythms - Junctional rhythm describes an abnormal heart rhythm resulting from impulses coming from a
from impulses coming ... #Cardiology #MedStudent ... #EKG #Junctional ... #Rhythms #Table
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... Control rate (e.g ... underlying cause #Stable ... #Tachycardia #Treatment ... #management #cardiology
Treatment of Stable Wide-Complex Tachycardia
Regular
 • If ventricular tachycardia or uncertain rhythm:
    -
Treatment of Stable ... nodal agents (e.g ... irregular protocol #Stable ... #Tachycardia #Treatment ... #management #cardiology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
cardiomyopathy (e.g ... Management during ... Delivery • Stable ... diagnosis #management #cardiology ... #treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Eosinophils < 100 Dosing ... : 250 mcg tablet ... increase to 500 mcg ... recommendations for the treatment